SELECT TAVR Trial to Compare Myval and Evolut Valves in Borderline Annuli Patients
The SELECT TAVR trial will assess the noninferiority of Myval transcatheter heart valves compared to Evolut valves in patients with borderline annular dimensions.
Therapeutic Area
Therapeutic area intelligence for Transcatheter Aortic Valve Replacement with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.